Farmacia clinica e dermatologia psoriasi
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
BIBLIOGRAFIA<br />
1. Tizek L, Schielein MC, Seifert F, Biedermann T et al. Skin diseases are more common than we think:<br />
screening results of an unreferred population at the Munich Oktoberfest, Journal of the European<br />
Academy of Dermatology and Venereology, Volume 33, Issue 7 p. 1421-1428<br />
2. Naldi L. Epidemiology of <strong>psoriasi</strong>s. Curr Drug Targets Inflamm Allergy. 2004 Jun;3(2):121-8. doi:<br />
10.2174/1568010043343958. PMID: 15180464.<br />
3. Vena GA, Altomare G, Ayala F, et al. Incidence of <strong>psoriasi</strong>s and association with comorbidities in<br />
Italy: a 5-year observational study from a national primary care database. Eur J Dermatol. 2010 Sep-<br />
Oct;20(5):593-8. doi: 10.1684/ejd.2010.1017. Epub 2010 Jul 7. PMID: 20605768.<br />
4. Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ,<br />
Thyssen JP, Egeberg A. Prevalence of psoriatic arthritis in patients with <strong>psoriasi</strong>s: A systematic review<br />
and meta-analysis of observational and <strong>clinica</strong>l studies. J Am Acad Dermatol. 2019 Jan;80(1):251-265.<br />
e19. doi: 10.1016/j.jaad.2018.06.027. Epub 2018 Jun 19. PMID: 29928910.<br />
5. Grivas A, Kapniari I, Tzannis K, et al. Gender differences in psoriatic arthritis disease characteristics:<br />
evidence for worse disease in women. Annals of the Rheumatic Diseases 2020;79:1692-1693.<br />
6. Il trattamento della <strong>psoriasi</strong> nell’adulto. Linea guida 25 Sistema nazionale per le linee guida<br />
dell’Istituto superiore di sanità (SNLG-ISS) (Data di aggiornamento: giugno 2016).<br />
7. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of<br />
<strong>psoriasi</strong>s vulgaris. J Am Acad Dermatol. 1985;13(3):450-6.<br />
8. La Psoriasi: una patologia cutanea multiorgano. Nuovi paradigmi e strategie di tutela assistenziale<br />
(Report del Progetto PACTA), 2016.<br />
9. World Health Organization, Global Report on Psoriasis, 2016.<br />
10. European Academy of Dermatology and Venereology (EADV). A variety of treatments [Internet]. 2019.<br />
Available at: https://eadv.org/cms-admin/showfile/9635-EADV%20PSORIASIS-9-A%20variety%20<br />
of%20treatments.pdf<br />
11. Documento di indirizzo regionale per l’impiego dei farmaci per il trattamento della <strong>psoriasi</strong> di grado<br />
moderato-severo. Azienda Zero, Regione del Veneto. Padova, ottobre 2019.<br />
12. Agenzia europea per i medicinali: Similar biological medicinal products containing biotechnologyderived<br />
proteins as active substance: non-<strong>clinica</strong>l and <strong>clinica</strong>l issues. EMEA/CHMP/ BMWP/42832/2005<br />
Rev. 1. http://www.ema. europa.eu/docs/en_GB/document_library/Scientific_ guideline/2015/01/<br />
WC500180219.pdf.<br />
13. Thaci D, Piaserico S, Warren RB et al. Five-year efficacy and safety of tildrakizumab in patients with<br />
moderate-to-severe <strong>psoriasi</strong>s who respond at week 28: pooled analyses of two randomized phase III<br />
<strong>clinica</strong>l trials (reSURFACE 1 and reSURFACE 2). British Journal of DermatologyVolume 185, Issue 2 p.<br />
323-334. https://doi.org/10.1111/bjd.19866<br />
14. Linee guida EuroGuiDerm sul trattamento sistemico della <strong>psoriasi</strong> volgare - Parte 1:<br />
raccomandazioni per Il trattamento e Il monitoraggio - Nast A Smith C et al. - Volume 34, Numero 11,<br />
novembre - 2020, pagine 2461-2498. https://www.eadv.org/<strong>clinica</strong>l-guidelines<br />
15. Linee Guida EuroGuiDerm sul trattamento sistemico della Psoriasi vulgaris - Parte 2: situazioni<br />
cliniche e comorbilità specifiche - Nast A, Smith C et al. - Volume 32, Numero 2, febbraio - 2021, Pagine<br />
281-317. https://www.eadv.org/<strong>clinica</strong>l-guidelines<br />
16. Gruppo di lavoro multidisciplinare in <strong>dermatologia</strong> Regione Emilia-Romagna. Trattamento sistemico<br />
della <strong>psoriasi</strong> cronica a placche moderata-grave con particolare riferimento ai farmaci biotecnologici.<br />
Linee guida terapeutiche n.1. Aggiornamento maggio 2019 Assessorato Cura della persona, Salute e<br />
Welfare Regione Emilia-Romagna.<br />
17. Boehncke WH and Schön MP. Psoriasis. Lancet 2015; 386: 983-94.<br />
18. Harden Jl et al. The immunogenetics of <strong>psoriasi</strong>s: a comprehensive review. J Autoimmun. 2015; 64:<br />
66-73.